Authors: Compter|, Inge(1)*[inge.compter@maastro.nl];Oldoni|, Emanuela(2);Houben|, Ruud(1);Van der Weijst|, Lotte(3);de Ruiter|, Michiel(4);Goris|, An(2);Holt|, Matthew(5);Deprez|, Sabine(6);Lambrecht|, Maarten(7);Lievens|, Yolande(3);Van Meerbeeck|, Jan P. (8);Schagen|, Sanne B.(9);Belderbos|, Jose S. A. (10);De Ruysscher|, Dirk K. M. (1);
(1)MAASTRO clinic- GROW- School for Oncology and Developmental Biology- Maastricht University Medical Centre, Dept. of Radiation Oncology, Maastricht, The Netherlands;(2)KU Leuven, Laboratory for Neuroimmunology- Department of Neurosciences, Leuven, Belgium;(3)Ghent University Hospital and Ghent University, Department of Radiation Oncology, Ghent, Belgium;(4)The Netherlands Cancer Institute- Antoni van Leeuwenhoek, Division of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands;(5)KU Leuven, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium;(6)KU Leuven, Department of Imaging and Pathology, Leuven, Belgium;(7)Leuven Kanker Instituut- UZ Gasthuisberg, Department of Radiotherapy Oncology, Leuven, Belgium;(8)Antwerp University Hospital UZA, Department of Pulmonology & Thoracic Oncology, Edegem, Belgium;(9)The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Division of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands;(10)The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Radiation Oncology, Amsterdam, The Netherlands;
Show Affiliations
Hide Affiliations